The Defense and Veterans Brain Injury Center   Report issue

Academic/Hospital
Founded: Washington D.C. United States (1992)

Organization Overview

First Clinical Trial
2000
NCT00208585
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Jorge Arango | The Defense and Veterans Brain Injury Center

Active Ingredients

Drugs in Other Trials (2)

citalopram (celexa) (1 trial)

sertraline (zoloft) (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 2
  • # of Trial APIs: 2